Indole-3-carbinol (I3C) as Leukemia Therapeutic Agents: Review. 2023

Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Leukemia or blood cancer was initially discovered in 1845 and this malignancy was reported in patients who had an amplified number of blood cells, in particular, White Blood Cells (WBC), due to this disease. The event of leukemia was further identified as a malignant hematopoietic disorder due to both uncontrolled and unlimited proliferation in combination with a lack of differentiation of the leukemic stem cells. Furthermore, 75 to 80% of the global population use herbal remedies as primary therapy, mainly because of their better efficiency and satisfaction, which elevate the human body symmetry with the minimum unwanted adverse effects. For the control of cancer, plant products, and fruits have been considered promising tools and are being consumed for centuries. Several plant extracts are also being used for the therapy and prevention of different types of known cancers. Indole-3-carbinol (I3C) is a natural material obtained from Brassica diversity of vegetables and has been reported to serve as a promising cancer preventative agent. In the present review, the authors mainly tried to focus on and emphasize I3C applications in leukemia treatment.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016588 Anticarcinogenic Agents Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. Anti-Carcinogenic Agents,Anti-Carcinogenic Drugs,Anti-Carcinogenic Effect,Anti-Carcinogenic Effects,Anticarcinogenic Drugs,Anticarcinogenic Effect,Anticarcinogenic Effects,Anticarcinogens,Agents, Anti-Carcinogenic,Agents, Anticarcinogenic,Anti Carcinogenic Agents,Anti Carcinogenic Drugs,Anti Carcinogenic Effect,Anti Carcinogenic Effects,Drugs, Anti-Carcinogenic,Drugs, Anticarcinogenic,Effect, Anti-Carcinogenic,Effect, Anticarcinogenic,Effects, Anti-Carcinogenic,Effects, Anticarcinogenic
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
February 2023, Pharmaceuticals (Basel, Switzerland),
Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
January 2019, Human & experimental toxicology,
Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
January 2010, In vivo (Athens, Greece),
Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
March 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
October 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
January 2003, Nutrition and cancer,
Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
August 1992, Journal of the National Cancer Institute,
Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
September 2011, Oncology reports,
Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
September 2014, Cancer biology & therapy,
Mojgan Noroozi Karimabad, and Maryam Mohamadi, and Seyedeh Atekeh Torabizadeh, and Gholamhossein Hassanshahi
December 2011, Medical oncology (Northwood, London, England),
Copied contents to your clipboard!